Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Concord Biotech Ltd. ( (IN:CONCORDBIO) ) has shared an announcement.
Concord Biotech Limited has revised the list of key managerial personnel (KMPs) authorized to determine the materiality of events and information and to make corresponding disclosures to stock exchanges under SEBI’s Listing Obligations and Disclosure Requirements. The updated authorized KMPs now include Chairman and Managing Director Sudhir Vaid, Joint Managing Director and CEO Ankur Vaid, Chief Financial Officer Raviraj Karia, and Company Secretary and Compliance Officer Hina Patel, a move that formalizes the company’s internal governance framework for market disclosures and reinforces its compliance processes for timely and accurate communication with investors and regulators.
More about Concord Biotech Ltd.
Concord Biotech Limited is an India-based biopharmaceutical company headquartered in Ahmedabad, Gujarat, operating in the biotech and pharmaceutical industry. The company focuses on manufacturing and supplying specialized pharmaceutical products, supported by registered office and plant facilities in Dholka, Ahmedabad district, and is listed on both the National Stock Exchange of India and BSE Limited under the symbol/scrip code CONCORDBIO/543960.
Average Trading Volume: 7,921
Technical Sentiment Signal: Sell
Current Market Cap: 144.3B INR
For detailed information about CONCORDBIO stock, go to TipRanks’ Stock Analysis page.